LabLinks: Targeting the tumor microenvironment

13 nov. 2023 08:30 - 17:30

Join us for this free in-person event, a collaboration between Netherlands Cancer Institute and Cell Press

Activation of endogenous immune responses by immune checkpoint blockade (ICB) has revolutionized cancer therapy and has become standard of care for several cancer types. However, many patients do not respond to ICB or other forms of immunotherapy or develop resistance over time. Therefore, a better understanding of the interactions within the tumor microenvironment (TME) is required to develop patient-tailored treatments that unleash an effective anti-tumor response. This LabLinks will bring together basic, translational and clinical scientists who study different components of the TME, in order to foster connections and bridge the gap between the bench and bedside.

This event is free to attend, though space is limited. Register today to join us in Amsterdam for this in-person event!

Speakers

Erik Sahai, Francis Crick Institute, UK
Julia Houthuijzen, Netherlands Cancer Institute
Tom Cupedo, Erasmus University Rotterdam
Daniele Tauriello, Radboud UMC
Monika Wolkers, Sanquin
Floris Foijer, University of Groningen
Noel de Miranda, Leiden University Medical Center
Daniela Thommen, Netherlands Cancer Institute
Ramon Arens, Leiden University Medical Center
Anne Rios, Princess Máxima Center
Sarah Derks, Amsterdam UMC

Organizers

Karin de Visser, Netherlands Cancer Institute
Julia Houthuijzen, Netherlands Cancer Institute
Feline Dijkgraaf, Cancer Cell, Cell Press
Kristan van der Vos, Cell Reports Medicine, Cell Press
Tatyana Kuznetsova, Cell Reports, Cell Press

Location

The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital
Piet Borst Auditorium
Plesmanlaan 121
1066 CX Amsterdam
The Netherlands

Route

For information about how to get to the Antoni van Leeuwenhoek either by car, bicycle or public transport), please look at Route (avl.nl)